EU sieht sich von Trumps neuen Generika-Zöllen nicht betroffen

The European Commission states that EU generic drugs are likely excluded from Trump's proposed 100% tariffs due to the 2025 Turnberry trade agreement, which mandates a 0% duty via the Most-Favored-Nation (MFN) clause. Trump's plan to impose tariffs on generics from 2028 aims to revive U.S. pharmaceutical production, but EU officials emphasize the agreement protects EU exports. The EU warns of potential retaliatory measures if the U.S. violates the accord.